Higher plasma CXCL12 levels predict incident myocardial infarction and death in chronic kidney disease: Findings fromthe chronic renal insufficiency cohort study

European Heart Journal

Volumn 35, Issue 31, 2014, Pages

  Mehta, Nehal N ^a   Matthews, Gregory J ^b   Krishnamoorthy, Parasuram ^c   Shah, Rhia ^c   McLaughlin, Catherine ^c   Patel, Parth ^c   Budoff, Matthew ^d   Chen, Jing ^e   Wolman, Melanie ^c   Go, Alan ^f   He, Jiang ^e   Kanetsky, Peter A ^c   Master, Stephen R ^c   Rader, Daniel J ^c   Raj, Dominic ^g   Gadegbeku, Crystal A ^h   Shah, Rachana ⁱ   Schreiber, Marty ^j   Fischer, Michael J ^k,l   Townsend, Raymond R ^m   Kusek, John ⁿ   Feldman, Harold I ^c,m   Foulkes, Andrea S ^b   Reilly, Muredach P ^c   more..

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^e TULANE UNIVERSITY   (United States)

^f DIVISION OF RESEARCH   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j LERNER RESEARCH INSTITUTE   (United States)

^k Jesse BrownVAMedical Center and University of Hospital and Health Sciences System   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m UNIVERSITY OF PENNSYLVANIA   (United States)

ⁿ NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

more..

Author keywords

Atherosclerosis; Chemokines; CXCL12; Myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ADULT; AGED; ALBUMIN CREATININE RATIO; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RENAL SYSTEM PARAMETERS; REVIEW; CHRONIC KIDNEY FAILURE; COMPLICATION; INCIDENTAL FINDING; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROGNOSIS; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; CHEMOKINE CXCL12; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENTAL FINDINGS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

EID: 84906517136     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht481     Document Type: Review

References (30)

1. Wilkins JT, Ning H, Berry J, Zhao L, Dyer AR, Lloyd-Jones DM. Lifetime risk and years lived free of total cardiovascular disease. JAMA 2012;308:1795-1801
2. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AF, Barbalic M, Gieger C, Absher D, Aherrahrou Z, Allayee H, Altshuler D, Anand SS, Andersen K, Anderson JL, Ardissino D, Ball SG, Balmforth AJ, Barnes TA, Becker DM, Becker LC, Berger K, Bis JC, Boekholdt SM, Boerwinkle E, Braund PS, Brown MJ, Burnett MS, Buysschaert I; Cardiogenics, Carlquist JF, Chen L, Cichon S, Codd V, Davies RW, Dedoussis G, Dehghan A, Demissie S, Devaney JM, Diemert P, Do R, Doering A, Eifert S, Mokhtari NE, Ellis SG, Elosua R, Engert JC, Epstein SE, de Faire U, Fischer M, Folsom AR, Freyer J, Gigante B, Girelli D, Gretarsdottir S, Gudnason V, Gulcher JR, Halperin E, Hammond N, Hazen SL, Hofman A, Horne BD, Illig T, Iribarren C, Jones GT, Jukema JW, Kaiser MA, Kaplan LM, Kastelein JJ, Khaw KT, Knowles JW, Kolovou G, Kong A, Laaksonen R, Lambrechts D, Leander K, Lettre G, Li M, LiebW, Loley C, Lotery AJ, Mannucci PM, Maouche S, Martinelli N, McKeown PP, Meisinger C, Meitinger T, Melander O, Merlini PA, Mooser V, Morgan T,Mühleisen TW, Muhlestein JB, Münzel T, Musunuru K, Nahrstaedt J, Nelson CP, Nöthen MM, Olivieri O, Patel RS, Patterson CC, Peters A, Peyvandi F, Qu L, Quyyumi AA, Rader DJ, Rallidis LS, Rice C, Rosendaal FR, Rubin D, Salomaa V, Sampietro ML, Sandhu MS, Schadt E, Schäfer A, Schillert A, Schreiber S, Schrezenmeir J, Schwartz SM, Siscovick DS, Sivananthan M, Sivapalaratnam S, Smith A, Smith TB, Snoep JD, Soranzo N, Spertus JA, Stark K, Stirrups K, Stoll M, Tang WH, Tennstedt S, Thorgeirsson G, Thorleifsson G, Tomaszewski M,Uitterlinden AG, van Rij AM, Voight BF, Wareham NJ, Wells GA, Wichmann HE, Wild PS, Willenborg C, Witteman JC, Wright BJ, Ye S, Zeller T, Ziegler A,Cambien F, Goodall AH, Cupples LA, Quertermous T, März W, Hengstenberg C,Blankenberg S, Ouwehand WH, Hall AS, Deloukas P, Thompson JR, Stefansson K,Roberts R, Thorsteinsdottir U, O'Donnell CJ, McPherson R, Erdmann J; CARDIo- GRAM Consortium, Samani NJ. Large-scale association analysis identifies 13 newsusceptibility loci for coronary artery disease. Nat Genet 2011;43:333-338
3. Kathiresan S, Voight BF, Purcell S, Musunuru K, Ardissino D, Mannucci PM, Anand S, Engert JC, Samani NJ, Schunkert H, Erdmann J, Reilly MP, Rader DJ, Morgan T, Spertus JA, Stoll M, Girelli D, McKeown PP, Patterson CC, Siscovick DS, O'Donnell CJ, Elosua R, Peltonen L, Salomaa V, Schwartz SM, Melander O, Altshuler D, Merlini PA, Berzuini C, Bernardinelli L, Peyvandi F, Tubaro M, Celli P, Ferrario M, Fetiveau R, Marziliano N, Casari G, Galli M, Ribichini F, Rossi M, Bernardi F, Zonzin P, Piazza A, Yee J, Friedlander Y, Marrugat J, Lucas G, Subirana I, Sala J, Ramos R, Meigs JB, Williams G, Nathan DM, MacRae CA, Havulinna AS, Berglund G, Hirschhorn JN, Asselta R, Duga S, Spreafico M, Daly MJ, Nemesh J, Korn JM, McCarroll SA, Surti A, Guiducci C, Gianniny L, Mirel D, Parkin M, Burtt N, Gabriel SB, Thompson JR, Braund PS, Wright BJ, Balmforth AJ, Ball SG, Hall AS, Linsel-Nitschke P, Lieb W, Ziegler A, Konig I, Hengstenberg C, Fischer M, Stark K, Grosshennig A, Preuss M, Wichmann HE, Schreiber S, Ouwehand W, Deloukas P, Scholz M, Cambien F, Li M, Chen Z, Wilensky R, Matthai W, Qasim A, Hakonarson HH, Devaney J, Burnett MS, Pichard AD, Kent KM, Satler L, Lindsay JM, Waksman R, Epstein SE, Scheffold T, Berger K, Huge A, Martinelli N, Olivieri O, Corrocher R, McKeown P, Erdmann E, Konig IR, Holm H, Thorleifsson G, Thorsteinsdottir U, Stefansson K, Do R, Xie C, Siscovick D. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009;41:334-341
4. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, Barrett JH, Konig IR, Stevens SE, Szymczak S, Tregouet DA, Iles MM, Pahlke F, Pollard H, Lieb W, Cambien F, Fischer M, Ouwehand W, Blankenberg S, Balmforth AJ, Baessler A, Ball SG, Strom TM, Braenne I, Gieger C, Deloukas P, Tobin MD, Ziegler A, Thompson JR, Schunkert H. Genomewide association analysis of coronary artery disease. N Engl J Med 2007;357:443-453
5. Consortium CD. A genome-wide association study in Europeans and south Asians identifies five new loci for coronary artery disease. Nat Genet 2011;43:339-344
6. Abi-Younes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD. The stromal cellderived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 2000;86:131-138
7. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, Honjo T. Structure and chromosomal localization of the human stromal cell-derived factor 1 (sdf1) gene. Genomics 1995;28:495-500
8. Mehta NN, Li M, William D, Khera AV, Derohannessian S, Qu L, Ferguson JF, McLaughlin C, Shaikh LH, Shah R, Patel PN, Bradfield JP, He J, Stylianou IM, Hakonarson H, Rader DJ, Reilly MP. The novel atherosclerosis locus at 10q11 regulates plasma cxcl12 levels. Eur Heart J 2011;32:963-971
9. Kiechl S, Laxton RC, Xiao Q, Hernesniemi JA, RaitakariOT, Kahonen M, Mayosi BM, Jula A, Moilanen L, Willeit J,Watkins H, Samani NJ, Lehtimaki TJ, Keavney B, Xu Q, Ye S. Coronary artery disease-related genetic variant on chromosome 10q11 is associated with carotid intima-media thickness and atherosclerosis. ArteriosclerThromb Vasc Biol 2010;30:2678-2683
10. Yu L, Cecil J, Peng SB, Schrementi J, Kovacevic S, Paul D, SuEW,Wang J. Identification and expression of novel isoforms of human stromal cell-derived factor 1. Gene 2006; 374:174-179
11. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J, Hoffmann J, Urbich C, Lehmann R, Arenzana-Seisdesdos F, Aicher A, Heeschen C, Fichtlscherer S, Zeiher AM, Dimmeler S. Impaired cxcr4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 2005;97:1142-1151
12. Zeiffer U, Schober A, Lietz M, Liehn EA, ErlW, Emans N, Yan ZQ,Weber C. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by p-selectin and chemokines. Circ Res 2004;94:776-784
13. Damas JK, Waehre T, Yndestad A, Ueland T, Muller F, Eiken HG, Holm AM, Halvorsen B, Froland SS, Gullestad L, Aukrust P. Stromal cell-derived factor-1alpha in unstable angina: Potential antiinflammatory and matrix-stabilizing effects. Circulation 2002;106:36-42
14. Schober A, Knarren S, Lietz M, Lin EA,Weber C. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein e-deficient mice. Circulation 2003;108:2491-2497
15. Zernecke A, Bot I, Djalali-Talab Y, Shagdarsuren E, Bidzhekov K, Meiler S, Krohn R, Schober A, Sperandio M, Soehnlein O, Bornemann J, Tacke F, Biessen EA,Weber C. Protective role of cxc receptor 4/cxc ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2008;102:209-217
16. Zernecke A, Schober A, Bot I, von Hundelshausen P, Liehn EA, Mopps B, Mericskay M, Gierschik P, Biessen EA,Weber C. Sdf-1alpha/cxcr4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005;96:784-791
17. Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, Shah VO, Balakrishnan VS, Guzman NJ, Girndt M, Periera BG, Feldman HI, Kusek JW, Joffe MM, Raj DS. Association between albuminuria, kidney function, and inflammatory biomarker profile in ckd in cric. Clin J Am Soc Nephrol 2012;7:1938-1946
18. Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED, Go AS, Hamm LL, He J, Hostetter T, Hsu CY, Jamerson K, Joffe M, Kusek JW, Landis JR, Lash JP, Miller ER, Mohler ER 3rd, Muntner P, Ojo AO, Rahman M, Townsend RR, Wright JT. The Chronic Renal Insufficiency Cohort (CRIC) study: Design and methods. J Am Soc Nephrol 2003;14:S148-S153
19. Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, Fink JC, Fischer MJ, Gadegbeku C, Hamm LL, Kusek JW, Landis JR, Narva A, Robinson N, Teal V, Feldman HI. Chronic Renal Insufficiency Cohort (CRIC) study: Baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol 2009;4:1302-1311.
20. Fischer MJ, Go AS, Lora CM, Ackerson L, Cohan J, Kusek JW, Mercado A, Ojo A, Ricardo AC, Rosen LK, Tao K, Xie D, Feldman HI, Lash JP. CKD in hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and hispanic-CRIC studies. Am J Kidney Dis 2011;58:214-227
21. Anderson AH, YangW, Hsu CY, Joffe MM, Leonard MB, Xie D, Chen J, Greene T, Jaar BG, Kao P, Kusek JW, Landis JR, Lash JP, Townsend RR,Weir MR, Feldman HI. Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis 2012;60:250-261
22. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of anewmarker: From area under theROCcurve to reclassification and beyond. Stat Med 2008;27:157-172; discussion 207-112
23. Chambless LE, Cummiskey CP, Cui G. Several methods to assess improvement in risk prediction models: Extension to survival analysis. Stat Med 2011;30:22-38
24. Luker K, Gupta M, Luker G. Bioluminescent cxcl12 fusion protein for cellular studies of cxcr4 and cxcr7. Biotechniques 2009;47:625-632
25. Luker KE, Steele JM, Mihalko LA, Ray P, Luker GD. Constitutive and chemokinedependent internalization and recycling of cxcr7 in breast cancer cells to degrade chemokine ligands. Oncogene 2010;29:4599-4610
26. Naumann U, Cameroni E, Pruenster M, Mahabaleshwar H, Raz E, Zerwes HG, Rot A, Thelen M. Cxcr7 functions as a scavenger for cxcl12 and cxcl11. PLoS One 2010;5: E9175
27. Mestas J, Hughes CC. Of mice and not men: Differences between mouse and human immunology. J Immunol 2004;172:2731-2738
28. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease.NEngl J Med 2008; 359:1897-1908
29. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009;301:2331-2339
30. Sanchez-Martin L, Estecha A, Samaniego R, Sanchez-Ramon S, Vega MA, Sanchez-Mateos P. The chemokine cxcl12 regulates monocyte-macrophage differentiation and runx3 expression. Blood 2011;117:88-97 Diseases Diseases Diseases Diseases Diseases Diseases